Prevnar 13 Cuts Pneumococcal Rate in Kids

MMG and PBEE faculty member, Keith Klugman, MD, PhD, was featured in the article, "Prevnar 13 cuts pneumococcal rate in kids" in MedPage Today on October 8, 2013. 

Within 2 years of approval for pediatric patients in 2011 to 2012, PCV13 vaccination was tied to a 59% reduction in invasive pneumococcal disease-related hospitalizations in children younger than 5 years old, and a 25% reduction in related hospitalizations in adults, according to Keith Klugman, MD, PhD and colleagues.